GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
THRESHOLD PHARMACEUT (THLD) [hlAlert]

Threshold is focused on the discovery, development, and commercialization of small molecule therapeutics based on `Metabolic Targeting.` This
approach targets abnormal glucose metabolism - a fundamental property of most solid tumors and other diseases. The company's initial focus is the treatment of cancer and benign prostatic hyperplasia, a disease characterized by overgrowth of the prostate.
( Total: 10 Current Stock Recommendations )
THRESHOLD PHARMACEUT   (10)
Hold 20% Buy 80%
Related companies
CELSION CORP   (5)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
BioSpecifics ...   (4)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Oncogenex ...   (8)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
galena biopharma   (11)
Buy 100%
Opko Health Inc   (3)
Buy 100%
Nutraceutical ...   (1)
Buy 100%
Filter by Gains:   
  
Rating:
Buy THLD
down 18.18 %
THRESHOLD PHARMACEUT (THLD) upgraded to Overweight by Piper Jaffray
Wednesday,  Feb 20, 2013  8:25 AM ET

Rating:
Hold THLD
1 Week Gains
down 9.33 %
THRESHOLD PHARMACEUT (THLD) rated Neutral by Piper Jaffray
Friday,  Jan 18, 2013  8:25 AM ET

Rating:
Buy THLD
down 47.60 %

Rating:
Buy THLD
down 49.12 %

Rating:
Buy THLD
down 47.60 %

Rating:
Buy THLD
down 51.20 %
THRESHOLD PHARMACEUT (THLD) rated Outperform by William Blair
Tuesday,  Jul 10, 2012  11:25 AM ET

Rating:
Buy THLD
down 52.12 %

Rating:
Buy THLD
down 44.59 %

Rating:
Buy THLD
down 33.38 %

Rating:
Buy THLD
up 213.95 %

Rating:
Hold THLD
THRESHOLD PHARMACEUT (THLD) rated Hold by Fortis Bank
Tuesday,  May 13, 2008  10:25 AM ET

Rating:
Hold THLD
Threshold Pharmaceuticals, Inc. (THLD) rated Hold
Monday,  Dec 3, 2007  9:25 AM ET

Your Recent Stocks
SymbolLastChange
THLD 4.12 up  7.57 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy